BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CytRx Corporation 

11726 San Vicente Blvd., Suite 650

Los Angeles  California  90049  U.S.A.
Phone: 310-826-5648 Fax: 310-826-6139


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
CytRx Corporation (CYTR) Added To Russell 3000® And Russell 2000® Indexes 6/30/2014 11:27:39 AM
CytRx Corporation (CYTR) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/29/2014 7:30:04 AM
CytRx Corporation (CYTR) Highlights Aldoxorubicin Data From Its Global Phase 2b Clinical Trial In First-Line Soft Tissue Sarcoma 5/28/2014 9:08:59 AM
CytRx Corporation (CYTR) Reports Completed Phase 1b/2 Progression-Free Survival And Overall Survival Aldoxorubicin Data In Second-Line Soft Tissue Sarcoma 5/5/2014 9:00:37 AM
CytRx Corporation (CYTR) Reports 2014 First Quarter Financial Results 5/1/2014 2:47:19 PM
CytRx Corporation (CYTR) To Present Completed Phase 1b/2 Progression-Free Survival And Overall Survival Aldoxorubicin Data In Second-Line Soft Tissue Sarcoma At Upcoming Research And Development Day 4/28/2014 9:01:59 AM
CytRx Corporation (CYTR) Announces Global Phase 2b Trial Of Aldoxorubicin In Soft Tissue Sarcomas Selected For Oral Presentation At The 2014 American Society of Clinical Oncology Annual Meeting 4/24/2014 7:15:54 AM
CytRx Corporation (CYTR) Announces Research And Development Day And Webcast 4/10/2014 7:14:31 AM
CytRx Corporation (CYTR) To Present Updated Aldoxorubicin Preclinical Glioblastoma Study Results At The 2014 American Association for Cancer Research Annual Meeting 4/3/2014 8:54:08 AM
CytRx Corporation (CYTR) Receives Orphan Medicinal Product Designation From European Commission (EC) For Aldoxorubicin In Soft Tissue Sarcoma 3/31/2014 8:04:35 AM
12345678910...